Have your own idea? Try our Stock Screener
French (CAC) Pharma Industry Analysis
UpdatedAug 01, 2026
DataAggregated Company Financials
Companies8
- 7D-1.0%
- 3M-5.9%
- 1Y-1.7%
- YTD-5.0%
Over the last 7 days, the Pharma industry has dropped 1.0%, driven by Sanofi declining 2.1%. Meanwhile, Ipsen actually outperformed within the industry, gaining 5.6% in the last week. As for the longer term, the industry's performance has been flat for the past year. Looking forward, earnings are forecast to grow by 18% annually.
Industry Valuation and Performance
Has the French Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 01 Aug 2026 | €107.6b | €54.9b | €5.3b | 18.5x | 20.5x | 2x |
| Mon, 29 Jun 2026 | €107.8b | €54.6b | €5.3b | 18.7x | 20.3x | 2x |
| Wed, 27 May 2026 | €109.4b | €54.6b | €5.3b | 19x | 20.6x | 2x |
| Fri, 24 Apr 2026 | €117.0b | €54.0b | €5.4b | 20x | 21.6x | 2.2x |
| Sun, 22 Mar 2026 | €110.7b | €54.0b | €5.4b | 19.5x | 20.5x | 2x |
| Tue, 17 Feb 2026 | €110.9b | €54.0b | €5.5b | 22.6x | 20.3x | 2.1x |
| Thu, 15 Jan 2026 | €116.4b | €53.0b | €7.0b | 22.7x | 16.7x | 2.2x |
| Sat, 13 Dec 2025 | €115.9b | €53.0b | €7.0b | 21.3x | 16.6x | 2.2x |
| Mon, 10 Nov 2025 | €118.6b | €53.0b | €7.0b | 21.7x | 17x | 2.2x |
| Wed, 08 Oct 2025 | €117.1b | €52.9b | €6.9b | 19.7x | 16.9x | 2.2x |
| Fri, 05 Sep 2025 | €110.4b | €52.8b | €6.9b | 18.8x | 16x | 2.1x |
| Sun, 03 Aug 2025 | €110.9b | €52.8b | €6.9b | 19x | 16x | 2.1x |
| Tue, 01 Jul 2025 | €112.7b | €52.1b | €6.7b | 18.4x | 16.9x | 2.2x |
| Thu, 29 May 2025 | €125.7b | €52.1b | €6.7b | 18.6x | 18.9x | 2.4x |
| Sat, 26 Apr 2025 | €125.2b | €52.1b | €6.7b | 18.2x | 18.8x | 2.4x |
| Mon, 24 Mar 2025 | €146.0b | €51.2b | €5.9b | 17.6x | 24.5x | 2.9x |
| Wed, 19 Feb 2025 | €143.3b | €51.2b | €5.8b | 18.4x | 24.8x | 2.8x |
| Fri, 17 Jan 2025 | €136.6b | €55.2b | €5.1b | 18.4x | 26.8x | 2.5x |
| Sun, 15 Dec 2024 | €125.1b | €55.2b | €5.1b | 19.5x | 24.5x | 2.3x |
| Tue, 12 Nov 2024 | €134.0b | €55.2b | €5.1b | 20.9x | 26.3x | 2.4x |
| Thu, 10 Oct 2024 | €141.3b | €53.8b | €4.8b | 22.7x | 29.4x | 2.6x |
| Sat, 07 Sep 2024 | €144.9b | €53.8b | €4.8b | 19.5x | 30.2x | 2.7x |
| Mon, 05 Aug 2024 | €134.0b | €53.8b | €4.8b | 21x | 27.9x | 2.5x |
| Wed, 03 Jul 2024 | €129.0b | €52.9b | €5.2b | 20x | 25x | 2.4x |
| Fri, 31 May 2024 | €125.7b | €52.9b | €5.2b | 21.6x | 24.3x | 2.4x |
| Sun, 28 Apr 2024 | €128.2b | €52.9b | €5.2b | 21.2x | 24.7x | 2.4x |
| Tue, 26 Mar 2024 | €125.9b | €52.7b | €6.0b | 20.7x | 20.8x | 2.4x |
| Thu, 22 Feb 2024 | €123.5b | €53.0b | €6.3b | 20.2x | 19.7x | 2.3x |
| Sat, 20 Jan 2024 | €132.0b | €52.2b | €9.7b | 19.6x | 13.6x | 2.5x |
| Mon, 18 Dec 2023 | €123.5b | €52.2b | €9.7b | 16.9x | 12.7x | 2.4x |
| Wed, 15 Nov 2023 | €119.5b | €52.2b | €9.7b | 17.3x | 12.3x | 2.3x |
| Fri, 13 Oct 2023 | €145.1b | €52.6b | €9.3b | 18.2x | 15.6x | 2.8x |
| Sun, 10 Sep 2023 | €141.0b | €52.6b | €9.3b | 20.8x | 15.2x | 2.7x |
| Tue, 08 Aug 2023 | €133.1b | €52.6b | €9.3b | 21.2x | 14.4x | 2.5x |
Price to Earnings Ratio
14.4x
Current Industry PE
- Investors are relatively neutral on the French Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 20.3x.
- The 3-year average PS ratio of 2.4x is higher than the industry's current PS ratio of 2.0x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have declined 17% per year over the last three years.
- Meanwhile revenues have remained mostly flat.
- This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the French Healthcare industry?
| FR Market | 1.33% | |
| Healthcare | -0.45% | |
| Pharma | -1.02% | |
| Pharma | -1.02% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| IPN Ipsen | €167.20 | 5.6% +€721.5m | 62.0% | PE26.7x | |
| VIRP Virbac | €337.50 | 1.7% +€46.1m | -0.7% | PE18.7x | |
| VETO Vetoquinol | €73.00 | 2.1% +€17.4m | -3.3% | PE14.8x | |
| ALTHX THX Pharma Société Anonyme | €4.30 | 14.4% +€7.5m | 59.3% | PS73.6x | |
| AB AB Science | €0.54 | 5.9% +€2.4m | -62.1% | PS36.9x |